''Joseph F. Finn, Jr., C.P.A. ('Finn'), Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc. ('Epix'), announced today that the MRI imaging intellectual properties of the EP-2104R MRI imaging agent, which will be auctioned on May 28, ...'